The 35th Annual Meeting of the Society for Medical Decision Making: Author Index M

Author Index: M

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

HOW TO DESIGN A RANDOMISED TRIAL FOR THE ESTIMATION OF TREATMENT, SELECTION AND PREFERENCE EFFECTS

PATIENT-PROVIDER CONVERSATIONS ABOUT ADVANCE CARE PLANNING

Mach, F.

M-1 ACCEPTABILITY AND EFFICACY OF A SYSTEMATIC SMOKING CESSATION INTERVENTION USING MOTIVATIONAL INTERVIEWING FOR SMOKERS HOSPITALIZED FOR ACUTE CORONARY SYNDROMES

Madan, J.

I-4 STRATEGIES FOR CALCULATING EVPPI EFFICIENTLY

Madhavan, G.

COURSE CANCELLED - PUBLIC POLICY DECISION SUPPORT USING MULTI-CRITERIA DECISION ANALYSIS: SMART VACCINES, A HANDS-ON EXAMPLE

Madhi, S. A.

THE VALUE OF REDUCING UNCERTAINTIES ABOUT VACCINATION PROGRAMS IN LOW- AND MIDDLE-INCOME COUNTRIES

O-4 EXPANDING THE RANGE OF COMPARATORS FOR COST-EFFECTIVENESS ANALYSES OF VACCINES: THE EXAMPLE OF A POTENTIAL GROUP B STREPTOCOCCAL (GBS) VACCINE PROGRAM FOR PREGNANT WOMEN IN SOUTH AFRICA

Maillart, L.

L-2 DYNAMIC ABANDON/EXTRACT DECISIONS FOR FAILED CARDIAC LEADS

ARE HOSPITALS “KEEPING UP WITH THE JONESES”?: ASSESSING THE SPATIAL AND TEMPORAL DIFFUSION OF THE SURGICAL ROBOT

N-1 THE EFFECT OF THE DIFFUSION OF THE SURGICAL ROBOT ON THE HOSPITAL-LEVEL UTILIZATION OF PARTIAL NEPHRECTOMY

Makic, M. B.

COMPARATIVE EFFECTIVENESS OF QUALITY IMPROVEMENT INTERVENTIONS FOR PRESSURE ULCER PREVENTION IN HOSPITALS

Manca, A.

I-2 ESTIMATING THE CLINICAL AND QUALITY OF LIFE BENEFITS OF ACUPUNCTURE FROM MULTIPLE PATIENT LEVEL DATA SOURCES: WHAT A PAIN!

L-1 10/19- PRESENTATION CANCELED. EXTENDING THE METHODS FOR THE ANALYSIS OF (AND MAPPING BETWEEN) PATIENT REPORTED OUTCOME MEASURES

Mandrik, O.

ECONOMIC BENEFITS OF SUBSIDIZING IN-VITRO FERTILIZATION FROM THE GOVERNMENT PERSPECTIVE IN BELARUS, KAZAKHSTAN, AND UKRAINE

Manne, S.

FINANCIAL CONCERNS AND PSYCHOSOCIAL FACTORS ASSOCIATED WITH DECISION MAKING ABOUT CLINICAL TRIALS

Marcantonio, E. R.

DEVELOPMENT AND EVALUATION OF A DECISION AID ON MAMMOGRAPHY SCREENING FOR WOMEN AGED 75 AND OLDER

Mark, D. B.

F-4 HARNESSING THE POWER OF BAYESIAN STATISTICS AND PATIENT-LEVEL DATA TO PREDICT THE EFFECTIVENESS OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) THERAPY IN PATIENT SUBGROUPS

Marra, C. A.

CAN PATIENT DECISION AIDS IMPROVE ADHERENCE AND BE COST EFFECTIVE? THE CASE OF OBSTRUCTIVE SLEEP APNEA

Marshall, J. K.

H-4 ADALIMUMAB VERSUS INFLIXIMAB FOR THE TREATMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS IN ADULT PATIENTS WITH NO PRIOR ANTI-TNF EXPERIENCE: AN INDIRECT COMPARISON META-ANALYSIS

COST-EFFECTIVENESS OF INTERSPINOUS SPACER DEVICES IN THE SURGICAL TREATMENT OF LUMBAR SPINAL STENOSIS

Martin, S.

SHORT-TERM ECONOMIC AND CLINICAL OUTCOMES OF CANAGLIFLOZIN COMPARED TO SITAGLIPTIN IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Martin, S.

O-2 ESTIMATING A COST EFFECTIVENESS THRESHOLD TO REFLECT OPPORTUNITY COSTS: THE CASE OF NICE IN THE UK

Martinez, K. A.

J-4 DECISION REGRET FOLLOWING TREATMENT FOR LOCALIZED BREAST CANCER: IS REGRET STABLE OVER TIME?

AUTOMATING QUALITY REVIEW FOR HEART FAILURE THROUGH A PERFORMANCE MEASUREMENT SYSTEM

Martirosyan, H.

DECISION MAKING IN DIABETES CARE IN ARMENIA

Masi, C.

RACIAL DIFFERENCES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS' TREATMENT PREFERENCES: A TWO-SITE STUDY

Mason, J. E.

METHODS FOR OPTIMIZING AND ANALYZING PATIENT OUTCOMES

STRATEGIC INVESTMENT TO INCREASE UTILIZATION OF STROKE REHABILITATION SERVICES: INSIGHTS FROM A SYSTEM DYNAMICS MODEL

INTRODUCTION TO SYSTEM DYNAMICS FOR HEALTH CARE SERVICES

Mathur, P.

DOES DOXYCYCLINE REDUCE THE RISK OF CLOSTRIDIUM DIFFICILE INFECTION IN PATIENTS WITH CELLULITIS?

M-1 ACCEPTABILITY AND EFFICACY OF A SYSTEMATIC SMOKING CESSATION INTERVENTION USING MOTIVATIONAL INTERVIEWING FOR SMOKERS HOSPITALIZED FOR ACUTE CORONARY SYNDROMES

Matthijsse, S. M.

THE HARMS OF PRIMARY SCREENING FOR HUMAN PAPILLOMAVIRUS IN UNCONTROLLED SCREENING SITUATIONS

Mattocks, K.

UNDERSTANDING HOW PATIENTS APPROACH TRADE-OFFS

McBride, T.

EFFECTIVE COMMUNICATION TO IMPROVE DECISION MAKING ABOUT HEALTH CARE PLANS

HOW TO DESIGN A RANDOMISED TRIAL FOR THE ESTIMATION OF TREATMENT, SELECTION AND PREFERENCE EFFECTS

M-2 GENERAL PRACTITIONERS' USE OF ABSOLUTE RISK VERSUS INDIVIDUAL RISK FACTORS IN CARDIOVASCULAR DISEASE PREVENTION: AN EXPERIMENTAL STUDY

THE IMPACT OF INJECTABLE ONCOLOGY DRUG SHORTAGES ON PATIENT CARE IN THE UNITED STATES

McElwee, N.

COMMITTEE & INTEREST GROUP MEETINGS: BUSINESS DEVELOPMENT COMMITTEE

McFall, S.

IMPACT OF FRAMING ON ACCEPTABILITY OF ACTIVE SURVEILLANCE FOR LOCALIZED PROSTATE CANCER

McKenzie, F.

EXPLORING 'RISK-COMMUNICATION' IN INITIAL PRENATAL CARE VISITS

K-1 "WHAT WOULD YOU DO?": OBSTETRICIANS' AND NEONATOLOGISTS' RESPONSES TO STANDARDIZED PATIENT REQUESTS FOR ADVICE REGARDING WHETHER TO ATTEMPT NEONATAL RESUSCITATION AT 23 WEEKS GESTATION

McKenzie, R. S.

ABIRATERONE ACETATE AND PREDNISONE REFILL CONSISTENCY IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS

CENTRAL NERVOUS SYSTEM COMORBIDITIES IN PATIENTS WITH METASTATIC CASTRATE-RESISTANT PROSTATE CANCER

McKinn, S.

M-2 GENERAL PRACTITIONERS' USE OF ABSOLUTE RISK VERSUS INDIVIDUAL RISK FACTORS IN CARDIOVASCULAR DISEASE PREVENTION: AN EXPERIMENTAL STUDY

Mclimont, M.

USING VALUE OF INFORMATION METHODS WHEN THE DISEASE IS RARE AND THE TREATMENT IS EXPENSIVE – THE EXAMPLE OF HEMOPHILIA A

Meads, D.

ASSESSING THE ACCEPTABILITY OF THE YORKSHIRE DIALYSIS DECISION AID TO PATIENTS

Mehta, S.

COMPARATIVE MEDICATION ADHERENCE RATES ACROSS THE DIFFERENT CLASSES OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAS) ANTIHYPERTENSIVE DRUGS IN PATIENTS WITH HYPERTENSION

Meigs, J.

DEVELOPMENT AND VALIDATION OF A COMPUTER-BASED ALGORITHM TO IDENTIFY FOREIGN-BORN PATIENTS WITH HIV INFECTION FROM THE ELECTRONIC MEDICAL RECORD

DOES VARIATION IN INDIVIDUALIZATION OF CARE CONTRIBUTE TO HEALTH DISPARITIES?

M-5 A PILOT RANDOMIZED CONTROLLED TRIAL OF PERSONALIZED DECISION SUPPORT FOR OLDER PATIENTS WITH DIABETES

TRA1-2 MODELLING TO SUPPORT REVISED WHO HIV TREATMENT GUIDELINES: CHALLENGES OF SYNTHESIZING RESULTS ACROSS MULTIPLE MODELS

MISPERCEPTION OF CANCER RISK IN PATIENTS WITH NEUROFIBROMATOSIS 1 AND 2

FINANCIAL CONCERNS AND PSYCHOSOCIAL FACTORS ASSOCIATED WITH DECISION MAKING ABOUT CLINICAL TRIALS

Meyer, C.

COST-EFFECTIVENESS OF ADVANCED CROSS-SECTIONAL IMAGING IN THE WORK-UP OF NEWLY DISCOVERED SOFT TISSUE MASSES

Meyer, M. E.

J-6 CHARACTERIZING SURGICAL TREATMENT DECISION INVOLVEMENT IN YOUNG WOMEN WITH BREAST CANCER

Meyer, R.

UTILIZATION PATTERNS OF ADALIMUMAB, ETANERCEPT, AND GOLIMUMAB IN RHEUMATOID ARTHRITIS

DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS BEFORE INITIATING ADALIMUMAB, ETANERCEPT OR GOLIMUMAB

Miao, R.

MUCH ADO ABOUT NOTHING? A LONGITUDINAL RETROSPECTIVE STUDY OF PATIENTS WITH TYPE-2 DIABETES TREATED WITH INSULIN GLARGINE AND SWITCHED TO INSULIN DETEMIR

Michaelidis, C. I.

G-1 COST-EFFECTIVENESS OF PROCALCITONIN-GUIDED ANTIBIOTIC THERAPY FOR OUTPATIENT MANAGEMENT OF ACUTE RESPIRATORY TRACT INFECTIONS IN ADULTS

Michie, S.

WHAT KINDS OF FEEDBACK ARE GIVEN TO HEALTH CARE PROVIDERS? A SYSTEMATIC REVIEW

Middeldorp, J. M.

IDENTIFICATION OF DOMAINS FOR THE DEVELOPMENT OF A DELIVERY-SPECIFIC UTILITY MEASURE IN OBSTETRICS

D-5 MODELLING THE OCCURRENCE OF INVASIVE BREAST CANCER IN WOMEN AGED 50-59 AND SIMULATING THE STUDY AND CONTROL GROUPS OF WOMEN IN THE CANADIAN NATIONAL BREAST SCREENING STUDY-2

Miller, D.

FINANCIAL CONCERNS AND PSYCHOSOCIAL FACTORS ASSOCIATED WITH DECISION MAKING ABOUT CLINICAL TRIALS

Miller, G.

STASTICAL METHODS TO SUPPORT MICROSIMULATIONS OF RISK-FACTOR INTERVENTIONS: RURAL CHINESE SCHOOL-BASED ANEMIA INTERVENTIONS

Miller, K.

THE COST-EFFECTIVENESS OF A MEDIA CAMPAIGN TO INCREASE ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS

B-1 DOES BIOMARKER INFORMATION IMPACT BREAST CANCER PATIENTS' PREFERENCES FOR THERAPY?

Miller, T.

TRANSLATION AND APPLICATION OF THE NUMERACY UNDERSTANDING IN MEDICINE INSTRUMENT IN JAPAN

Miller-Halegoua, S.

FINANCIAL CONCERNS AND PSYCHOSOCIAL FACTORS ASSOCIATED WITH DECISION MAKING ABOUT CLINICAL TRIALS

Mills, E. J.

CRITICAL APPRAISAL OF MULTIPLE TREATMENT COMPARISONS FOR HEALTH TECHNOLOGY ASSESSMENTS

H-4 ADALIMUMAB VERSUS INFLIXIMAB FOR THE TREATMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS IN ADULT PATIENTS WITH NO PRIOR ANTI-TNF EXPERIENCE: AN INDIRECT COMPARISON META-ANALYSIS

Mirza, S. K.

COST-EFFECTIVENESS OF INTERSPINOUS SPACER DEVICES IN THE SURGICAL TREATMENT OF LUMBAR SPINAL STENOSIS

COMPARATIVE EFFECTIVENESS OF QUALITY IMPROVEMENT INTERVENTIONS FOR PRESSURE ULCER PREVENTION IN HOSPITALS

Mohamed, A.

OVERLAP AND THE EFFICIENCY OF DISCRETE-CHOICE EXPERIMENTS: EVIDENCE FROM A RANDOMIZED EXPERIMENT

G-6 USING A MODEL-BASED ECONOMIC EVALUATION IN A FEASIBILITY STUDY TO INFORM THE VALUE OF A FUTURE TRIAL: A CASE STUDY OF GROMMETS-INSERTION FOR CHILDREN WITH CLEFT PALATE AFFECTED BY OTITIS MEDIA WITH EFFUSION

Mompe, A.

PATIENT CENTERED APPROACHES FOR MEDICAL DECISION MAKING: FINDINGS FROM THE NATIONAL HEALTHCARE QUALITY AND DISPARITIES REPORTS (NHQR-DR)

Monane, M.

THE CLINICAL UTILITY OF NOVEL GENOMIC-BASED TEST ON MEDICAL DECISION MAKING FOR THE EVALUATION OF OBSTRUCTIVE CORONARY ARTERY DISEASE IN THE AMBULATORY CARE SETTING

Montaner, J.

A TWO-PART MODEL FOR THE COSTS OF HEALTH RESOURCE UTILIZATION AMONG INDIVIDUALS WITH HIV/AIDS

Mooney, A.

ASSESSING THE ACCEPTABILITY OF THE YORKSHIRE DIALYSIS DECISION AID TO PATIENTS

SHOULD PATIENT NARRATIVES BE USED TO SUPPORT PEOPLE'S TREATMENT DECISION MAKING: AN EXPERIMENTAL STUDY ABOUT DIALYSIS OPTIONS?

Moore, C. G.

DECISION QUALITY AND THE USE OF CARDIAC RHYTHM REGULATING DEVICES IN OLDER ADULTS WITH COGNITIVE IMPAIRMENT

Moran, A. E.

F-3 CALIBRATION OF A MARKOV CARDIOVASCULAR DISEASE MICROSIMULATION MODEL USING AN ESTABLISHED CELL-BASED SIMULATION MODEL

RETROSPECTIVE ANALYSIS OF EXENATIDE TWICE DAILY COMPARED TO LONG-ACTING INSULIN ANALOGS IN A VETERAN POPULATION

ASSOCIATION BETWEEN PHYSICIAN-PATIENT RELATIONSHIP AND DECISIONAL REGRET, CONFLICT AND SATISFACTION ABOUT SURGICAL DECISIONS

TRANSLATING KNOWLEDGE INTO ACTION: A COGNITIVE PERSPECTIVE ON THE INFORMATION NEEDS OF HEALTHCARE DECISION-MAKERS IN THE US

B-4 GOAL SETTING DURING PERIODIC HEALTH EXAMS: WHAT TYPES OF GOALS ARE SET AND WHAT IMPACT DOES IT HAVE ON THE VISIT?

Morris, S.

ECONOMIC EVALUATION OF MENINGOCOCCAL SEROGROUP B CHILDHOOD VACCINATION IN ONTARIO, CANADA

A COST-EFFECTIVENESS ANALYSIS OF THE IMPLEMENTATION OF ROUTINE ROTAVIRUS VACCINATION IN INDIA

Mortaz Hedjri, S.

MAPPING STANDARD GAMBLE AND TIME TRADE-OFF UTILITIES TO THE MEDICAL OUTCOMES STUDY-HIV HEALTH SURVEY AND PATIENT SYMPTOMS

Moss, A. J.

F-4 HARNESSING THE POWER OF BAYESIAN STATISTICS AND PATIENT-LEVEL DATA TO PREDICT THE EFFECTIVENESS OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) THERAPY IN PATIENT SUBGROUPS

THE IMPACT OF INJECTABLE ONCOLOGY DRUG SHORTAGES ON PATIENT CARE IN THE UNITED STATES

Moy, B.

E-2 INCORPORATING SHARED DECISION MAKING AS PART OF PERFORMANCE MEASUREMENT: THE CHALLENGE OF TIMING

Moy, E.

PATIENT CENTERED APPROACHES FOR MEDICAL DECISION MAKING: FINDINGS FROM THE NATIONAL HEALTHCARE QUALITY AND DISPARITIES REPORTS (NHQR-DR)

Mühlberger, N.

D-2 THE BENEFIT-HARM FRONTIER OF HPV PRIMARY SCREENING FOR CERVICAL CANCER IN GERMANY: ESTIMATES FROM A SYSTEMATIC DECISION -ANALYSIS

Mullen, P.

IMPACT OF FRAMING ON ACCEPTABILITY OF ACTIVE SURVEILLANCE FOR LOCALIZED PROSTATE CANCER

COST ANALYSIS OF SKELETAL RELATED EVENTS AMONG ELDERLY MEN WITH STAGE IV METASTATIC PROSTATE CANCER

Muriello, P. F.

J-3 ADDING NATURAL FREQUENCY DATA TO A DECISION AID FOR COLORECTAL CANCER SCREENING: RESULTS OF A RANDOMIZED TRIAL

G-5 COST-EFFECTIVENESS ANALYSIS OF THE NATIONAL PERINATAL HEPATITIS B PREVENTION PROGRAM

Musch, D. C.

H-5 LOGISTIC REGRESSION WITH FILTERED DATA TO IMPROVE PROGRESSION IDENTIFICATION

TRA1-1 COMPARISON OF CONTROL ALGORITHMS FOR SCHEDULING TESTING VISITS

DECISION SUPPORT FOR SCREENING MAMMOGRAPHY: EVALUATION OF A WEB-BASED DECISION AID FOR WOMEN IN THEIR 40'S

MISPERCEPTION OF CANCER RISK IN PATIENTS WITH NEUROFIBROMATOSIS 1 AND 2

Myers, R. E.

DECISION COUNSELING ABOUT ACTIVE SURVEILLANCE AND ACTIVE TREATMENT FOR EARLY STAGE LOW RISK PROSTATE CANCER PATIENTS

A DECISION SUPPORT INTERVENTION FOR PATIENTS AT-RISK FOR HEPATITIS C: IMPACT ON KNOWLEDGE, INFORMED DECISION MAKING, AND TESTING

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z